Document Detail


Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
MedLine Citation:
PMID:  20444901     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Human T-lymphotropic virus 1 (HTLV-1) causes an aggressive malignancy of T lymphocytes called adult T-cell leukemia/lymphoma (ATLL), and expression of HTLV-1 Tax influences cell survival, proliferation, and genomic stability in the infected T lymphocytes. Cyclin-dependent kinase inhibitor 1A (CDKN1A/p21(waf1/Cip1)) is upregulated by Tax, without perturbation of cell cycle control. During an analysis of the gene expression profiles of ATLL cells, we found very low expression of CDKN1A in ATLL-derived cell lines and ATLL cells from patient samples, and epigenetic abnormalities including promoter methylation are one of the mechanisms for the low CDKN1A expression in ATLL cells. Three HTLV-1-infected cell lines showed high levels of expression of both CDKN1A and Tax, but expression of CDKN1A was detected in only two of six ATLL-derived cell lines. In both the HTLV-1-infected and ATLL cell lines, we found that activated Akt phosphorylates CDKN1A at threonine 145 (T145), leading to cytoplasmic localization of CDKNIA. In HTLV-1-infected cell lines, cytoplasmic CDKN1A did not inhibit the cell cycle after UV irradiation; however, following treatment with LY294002, a PI3K inhibitor, CDKN1A was dephosphorylated and relocalized to the nucleus, resulting in suppression of the cell cycle. In the ATLL cell lines, treatment with LY294002 did not inhibit the cell cycle but induced apoptosis with the cytoplasmic localization. Therefore, the low CDKN1A expression in ATLL cells may be a key player in ATLL leukemogenesis, and the abnormal genomic methylation may influence the expression of not only HTLV-1 Tax but also CDKN1A during long-term development of ATLL from the HTLV-1-infected T lymphocytes.
Authors:
Masaaki Watanabe; Shingo Nakahata; Makoto Hamasaki; Yusuke Saito; Yohei Kawano; Tomonori Hidaka; Kiyoshi Yamashita; Kazumi Umeki; Tomohiko Taki; Masafumi Taniwaki; Akihiko Okayama; Kazuhiro Morishita
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-05
Journal Detail:
Title:  Journal of virology     Volume:  84     ISSN:  1098-5514     ISO Abbreviation:  J. Virol.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-21     Completed Date:  2010-08-11     Revised Date:  2011-07-19    
Medline Journal Info:
Nlm Unique ID:  0113724     Medline TA:  J Virol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  6966-77     Citation Subset:  IM    
Affiliation:
Division of Tumor and Cellular Biochemistry, Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, Kiyotake, Miyazaki, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cell Cycle / physiology
Cell Line
Cyclin-Dependent Kinase Inhibitor p21 / genetics,  metabolism*
Down-Regulation*
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Products, tax / genetics,  metabolism
Human T-lymphotropic virus 1 / genetics,  metabolism*
Humans
Leukemia-Lymphoma, Adult T-Cell / genetics,  metabolism*,  virology*
Microarray Analysis
Promoter Regions, Genetic
Proto-Oncogene Proteins c-akt / genetics,  metabolism
Chemical
Reg. No./Substance:
0/CDKN1A protein, human; 0/Cyclin-Dependent Kinase Inhibitor p21; 0/Gene Products, tax; 0/tax protein, Human T-lymphotrophic virus 1; EC 2.7.11.1/Proto-Oncogene Proteins c-akt
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency...
Next Document:  Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening ...